Skip to main content
3 min read

Heidi Overton Is As Shifty as a Window

Murray pressed Overton on mifepristone safety and whether IUDs are abortifacients.

Heidi Overton Is As Shifty as a Window
Image · Jezebel

SOURCE CHECK

TAP FOR WHY
Outlet credibilityJezebel59/100 MEDIUM
This article1 analysis · Sep 27, 2026
Jezebel
Sep 25, 2026
tl;dr

At her Senate confirmation hearing, FDA commissioner nominee Heidi Overton declined to state whether mifepristone is safe or whether IUDs are abortifacients. Sen. Patty Murray challenged those answers, which the article presents as raising concerns about Overton’s approach to abortion medication and birth control.

Community verdict

10 VOTES
How does this story look for
Patty Murray D · WA · SEN
● OPEN

People in this story

SWIPE →
Patty Murray
D · WA · SEN

Questioned FDA commissioner nominee Heidi Overton at the confirmation hearing

PRIMARY SUBJECT
Donald Trump
R · President of the United States

President who selected Overton and whose administration initiated the mifepristone re-review

Josh Hawley
R · MO · SEN

Senator whose promotion of a study is described as preceding the mifepristone re-review

ALSO MENTIONED  Heidi Overton, Trump’s nominee to lead the FDA; Marty Makary, Former FDA commissioner whom Overton was selected to replace; Mini Timmaraju, Reproductive Freedom for All president and CEO quoted criticizing Trump’s appointments; Nicole Saphier, Surgeon general hopeful whose hearing was postponed

Discussion · 0

What's your take?

Loading comments…